AprilBio Plunges 20%; Peptron Tempers Lilly Deal Hopes[K-Bio Pulse]

• 김새미
• 2026.10.06
• 오전 09:10

GI Innovation, G2G Bio Jump 20% on Licensing Deal Hopes [K-bio pulse]

• 김진수
• 2026.10.02
• 오전 07:20

Helixmith, Genome & Company Surge on Royalty [K-bio pulse]

• 김승권
• 2026.10.01
• 오전 06:05

AriBio Holdings Hits Lower Limit After Scrapping Merger With AriBio [K-bio bulse]

• 김승권
• 2026.09.30
• 오전 06:40

• BNCKorea
• VUNO
• HLB
• phamedaily

Investor Sentiment Rebounds, HLB·VUNO·BNC Korea Drive Market Turning Point[K-Bio Pulse]

• 유진희
• 2026.09.29
• 오전 08:00

Proteina Gains on AI Data...Ingenia Advances Phase 3[K-Bio Pulse]

• 김지완
• 2026.09.28
• 오전 07:30

• 팜이데일리
• 그래피
• 레이
• 메가젠임플란트

Graphy Chairman Details Ray Strategy, MegaGen Relationship

• 나은경
• 2026.09.28
• 오전 06:00

Cellid, BlueMtec Rally on Change-of-Control Deals; Inventera Gains[K-bio pulse]

• 김진수
• 2026.09.23
• 오전 08:35

Orum Plunges on Clinical Halt; ENCell, VUNO Jump[K-Bio Pulse]

• 김새미
• 2026.09.21
• 오전 07:00

Orum Loses Sole Clinical Asset After BMS Return[K-Bio Pulse]

• 김지완
• 2026.09.18
• 오전 07:40